ArticleDermatology and therapy2025

Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients with Psoriasis: An Observational Study.

Aikaterini Tsiogka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.